A pilot trial of movement-based pelvic floor physical therapy to address pelvic floor myofascial pain and lower urinary tract symptoms

Introduction and hypothesis Pelvic floor myofascial pain (PFMP) is associated with lower urinary tract symptoms (LUTS). The objective of this study was to test movement-based pelvic floor physical therapy (PT) for patients with PFMP and LUTS. We hypothesized that movement-based PT designed to target...

Full description

Saved in:
Bibliographic Details
Published in:International Urogynecology Journal 2023-06, Vol.34 (6), p.1261-1270
Main Authors: Meister, Melanie R., Sutcliffe, Siobhan, Ghetti, Chiara, Chu, Christine M., Spitznagle, Theresa M., Lowder, Jerry L.
Format: Article
Language:English
Subjects:
Gynecology
Humans
Lower Urinary Tract Symptoms - complications
Medicine
Medicine & Public Health
Myofascial Pain Syndromes - complications
Myofascial Pain Syndromes - therapy
Original Article
Pain
Pelvic Floor
Pelvis
Physical therapy
Physical Therapy Modalities
Pilot Projects
Urogenital system
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction and hypothesis Pelvic floor myofascial pain (PFMP) is associated with lower urinary tract symptoms (LUTS). The objective of this study was to test movement-based pelvic floor physical therapy (PT) for patients with PFMP and LUTS. We hypothesized that movement-based PT designed to target PFMP would result in significant improvement in both PFMP and concomitant LUTS. Methods This pilot trial enrolled patients with moderate-to-severe PFMP on palpation who were referred to movement-based PT to diagnose and treat pelvic floor dysfunction in the context of body alignment and movement patterns. The primary outcome was change in Urogenital Distress Inventory (UDI) scores after PT. Factors associated with PT attendance were also measured. We aimed to enroll 55 participants to achieve 80% power to detect a difference in 11 points on the UDI scores with an alpha-level of 0.05, accounting for a 10% loss to follow-up. The sample size was increased to 65 owing to a higher-than-expected loss-to-follow-up rate. Results Sixty-five patients were enrolled and 62 analyzed. Thirty-eight (61.3%) attended PT, and 30 (48.4%) completed a follow-up PT Attendance (PTA) survey. Overall, UDI score and irritative, obstructive, and stress subscales ( p
ISSN:0937-3462
1433-3023
DOI:10.1007/s00192-022-05353-9